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A B S T R A C T
Background
Hypertonic solutions are considered to have a greater ability to expand blood volume and thus elevate blood pressure and can be
administered as a small volume infusion over a short time period. On the other hand, the use of hypertonic solutions for volume
replacement may also have important disadvantages.
Objectives
To determine whether hypertonic crystalloid decreases mortality in patients with hypovolaemia.
Search methods
We searched the Cochrane Injuries Group’s specialised register, MEDLINE, EMBASE, The Cochrane Library, issue 3, 2007, The
National Research Register issue 3, 2007 and the British Library’s Electronic Table of Contents ZETOC. We also checked reference
lists of all articles identified. The searches were last updated in October 2007
Selection criteria
Randomised trials comparing hypertonic to isotonic and near isotonic crystalloid in patients with trauma or burns or who were
undergoing surgery.
Data collection and analysis
Two authors independently extracted the data and assessed the quality of the trials.
Main results
Fourteen trials with a total of 956 participants are included in the meta-analysis. The pooled relative risk (RR) for death in trauma
patients was 0.84 (95% confidence interval [CI] 0.69 to1.04); in patients with burns 1.49 (95% CI 0.56 to 3.95); and in patients
undergoing surgery 0.51 (95% CI 0.09 to 2.73). In the one trial that gave data on disability using the Glasgow outcome scale, the
relative risk for a poor outcome was 1.00 (95% CI 0.82 to 1.22).
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Authors’ conclusions
This review does not give us enough data to be able to say whether hypertonic crystalloid is better than isotonic and near isotonic
crystalloid for the resuscitation of patients with trauma or burns, or those undergoing surgery. However, the confidence intervals are
wide and do not exclude clinically significant differences. Further trials which clearly state the type and amount of fluid used and that
are large enough to detect a clinically important difference are needed.
P L A I N L A N G U A G E S U M M A R Y
More evidence needed as to the best concentration of crystalloid to use in resuscitation fluids
Fluid resuscitation is usually given when a patient has lost a lot of blood, but there is continuing uncertainty as to the best sort of fluid
to use. Some of the fluids used contain substances classified as “crystalloids”, but should the concentration of crystalloids in the fluid be
about the same as their concentration in human blood (“isotonic”) or higher (“hypertonic”)? It is commonly believed that hypertonic
crystalloid is the more effective at increasing blood volume but that there could be some disadvantages to using it. This review has
assessed the evidence from studies that compared the use of the two types of fluid with patients who had been injured or burned, or
were having surgery. Not enough evidence is available, however, to decide which crystalloid concentration is best. More research is
needed.
B A C K G R O U N D
Fluid resuscitation is a mainstay of the medical management of
haemorrhagic hypovolaemia. However, there is continuing uncer-
tainty about the most appropriate fluid (Krausz 1995). Isotonic
crystalloid solutions are often used to replace blood loss until a
blood transfusion can be administered, but the wish to administer
large volumes (advanced trauma life support [ATLS] guidelines
suggest two litres of isotonic crystalloid), particularly in the pre-
hospital phase when there may be problems with venous access,
has stimulated the development of alternative approaches. One
such approach is the use of hypertonic saline. Hypertonic solu-
tions are considered to have a greater ability to expand blood vol-
ume and thus elevate blood pressure, and can be administered as
a small volume infusion over a short time period (Krausz 1995).
Infusion of hypertonic saline is believed to act by causing an os-
motic shift of fluid from the intracellular and interstitial spaces
to the extracellular compartment. The resulting auto-transfusion
of fluid increases blood pressure and circulating volume. The use
of hypertonic solutions has the potential to provide rapid volume
resuscitation but with less interstitial oedema than with isotonic
saline solutions (Shackford 1983).
It has also been suggested that hypertonic solutions may be
the fluid of choice in hypovolaemic patients with head injuries
(Khanna 2000; Peterson 2000; Walsh 1991). Cerebral perfusion
pressure (CPP) depends on both intracranial pressure (ICP) and
mean arterial blood pressure. (CPP =mean arterial blood pressure -
mean ICP.) Patients in hypovolaemic shockwho have head injuries
may require rapid blood pressure elevation to maintain cerebral
perfusion pressure, but excessive fluid and salt administration may
result in brain swelling with an increase in intracranial pressure.
Hypertonic solutions, however, are believed to reduce intracranial
pressure by establishing an osmotic gradient across the blood brain
barrier that draws water from the brain tissue into the vascular
space (Fisher 1992). Hypertonic solutions, therefore, have the po-
tential to restore blood pressure rapidly, but without increasing
intracranial pressure. Hypertonic solutions are also thought to be
beneficial in preventing the ’water logging’ effect when there is in-
terstitial lung injury, for example as occurs both in elective surgery
and in trauma.
On the other hand, the use of hypertonic solutions for volume
replacement may also have important disadvantages. In situations
where haemorrhage is on-going, hypertonic solutions may result
in continued bleeding from injured vessels. A potential problem
in head injuries is that, in patients with a disrupted blood brain
barrier, excess sodium may leak into brain tissue drawing water
with it, thus worsening cerebral oedema. At present, there are no
clinical ways to assess the integrity of the blood brain barrier. Fur-
thermore, not only could the integrity of the blood brain barrier
vary among patients with head injury, but it might also vary in
different parts of the brain in a single patient. The possibility that
hypertonic fluids may worsen outcome following head injury can-
not therefore be dismissed (Krausz 1995, Shenkin 1976).
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O B J E C T I V E S
To determine whether hypertonic crystalloid decreases mortality
in patients with hypovolaemia with and without head injuries, we
conducted a systematic review of randomised controlled trials.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials. Crossover trials were excluded.
Types of participants
Patients with trauma, burns or surgery. Trials in both the pre-
hospital and hospital setting were included.
Types of interventions
Trials that compare hypertonic to isotonic and near isotonic crys-
talloid. Trials of hypertonic crystalloid with an add-on colloid (e.g.
hypertonic saline and dextran) are not included. This compari-
son has been dealt with in a previous systematic review by the
Cochrane Injuries Group (Perel 2007).
Types of outcome measures
The principal outcome measure is mortality from all causes and
disability assessed at the end of the follow-up period scheduled for
each trial. Disability was assessed using the Glasgow outcome scale
(Jennett 1975) which includes the following categories: death,
persistent vegetative state, severely disabled, moderately disabled
and good recovery. For the purpose of this review, the scale was
dichotomised with death, persistent vegetative state and severe
disability denoting a poor outcome, and moderate disability and
good recovery denoting a good outcome.
Intermediate physiological outcomes were not used for several rea-
sons. Such outcomes are subject to intra and inter-observer vari-
ation, they have no face value to patients and relatives, and those
seen as appropriate are not stable over time. Also, there would
need to exist a strong predictive relationship between the variable
and mortality.
Search methods for identification of studies
The search was last updated in October 2007.
Electronic searches
We searched the following electronic databases;
• Cochrane Injuries Group’s specialised register
• CENTRAL
• MEDLINE
• EMBASE
• National Research Register
• Zetoc.
The original search strategies were based on the terms listed below.
The full search strategies for the most recent search update are
listed in Appendix 1.
1. Saline solutions hypertonic (MeSH)
2. Isotonic solutions (MeSH)
3. Hypertonic or isotonic or hyperosmotic or hyperoncotic
4. Hypotensive resuscitation
5. #1 or #2 or #3 or #4
6. random*
7. double-blind-procedure (MeSH)
8. #6 or #7
9. #5 and #8
Data collection and analysis
Selection of studies
One reviewer (FB) examined the electronic search results for re-
ports of possibly relevant trials and these reports were retrieved in
full. Two reviewers applied the selection criteria independently to
the trial reports, resolving disagreements by discussion.
Data extraction and management
Two reviewers independently extracted information on the follow-
ing: study quality, number of randomised patients, type of partici-
pants and the interventions. The outcome data sought were num-
ber of deaths and disability. The reviewers were not blinded to the
authors or journal when doing this, as evidence for the value of
this is far from conclusive (Berlin 1997). Results were compared
and any differences resolved by discussion.
For each trial the relative risk of death and 95%confidence interval
were calculated. The relative risk was chosen as it is more readily
applied to the clinical situation.
The groups of trials were examined for statistical evidence of het-
erogeneity using a chi squared test. As there was no obvious het-
erogeneity on visual inspection or statistical testing, pooled rela-
tive risks (RR) and 95% confidence intervals (CIs) were calculated
using a fixed effects model.
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Assessment of risk of bias in included studies
Since there is evidence that the quality of allocation concealment
particularly affects the results of studies (Schulz 1995), two review-
ers scored this quality on the scale used by Schulz (Schulz 1995) as
shown below, assigning C to poorest quality and A to best quality:
A = trials deemed to have taken adequate measures to conceal allo-
cation (i.e. central randomisation; numbered or coded bottles or
containers; drugs prepared by the pharmacy; serially numbered,
opaque, sealed envelopes; or other description that contained ele-
ments convincing of concealment).
B = trials in which the authors either did not report an allocation
concealment approach at all or reported an approach that did not
fall into one of the other categories.
C = trials in which concealment was inadequate (such as alterna-
tion or reference to case record numbers or to dates of birth)
In addition, data was extracted on blinding and loss to follow-
up. Where the method used to conceal allocation was not clearly
reported, the author was contacted, if possible, for clarification.
We then compared the scores allocated and resolved differences
by discussion.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Eighteen randomised controlled trials were identified by the
searches. However, four (Gunn 1989; McGough 1990; Younes
1988a; Younes 1988b) did not provide data on the outcomes spec-
ified in the review. Details of these studies are also reported in the
table of included studies for completeness.
In the 14 trials reported in the meta-analysis, patients with burns
were included in three (n=72) (Bortolani 1996; Caldwell 1979;
Jelenko 1978), patients undergoing surgery in five (n= 230) (Croft
1992; Cross 1989; Jarvela 2002; Shackford 1983; Shackford 1987)
and trauma patients in six (n= 654) (Cooper 2004; Simma 1998;
Vassar 1990; Vassar 1993a; Vassar 1993b; Younes 1992).
Eleven trials compared hypertonic saline versus Ringer’s lactate
(Bortolani 1996; Caldwell 1979; Cooper 2004; Croft 1992;
Jelenko 1978; Shackford 1983; Shackford 1987; Simma 1998;
Vassar 1990; Vassar 1993a; Vassar 1993b), and the rest compared
hypertonic saline with normal saline.
For more detailed descriptions of individual studies, please see the
table of included studies. No additional studies were identified for
this latest update.
Risk of bias in included studies
Allocation concealment was judged to be adequate in five trials
(Cooper 2004; Simma 1998; Vassar 1990; Vassar 1993a; Vassar
1993b), inadequate in three (Caldwell 1979; Shackford 1983;
Shackford 1987), and unclear in the rest. Five trials reported the
use of identical bags or containers for the fluids, so that staff were
blinded to the identify of the solutions (Cooper 2004; Cross 1989;
Vassar 1990; Vassar 1993a; Vassar 1993b).
Effects of interventions
Death was reported either in the paper, or the information was
obtained by contacting the researcher, in 14 studies. Data on death
were not obtained for four trials (Gunn 1989; McGough 1990;
Younes 1988a; Younes 1988b). Data on disability was obtained
from the author of one trial (Cooper 2004).
Due to the clinical heterogeneity of the different patient groups
it was felt to be inappropriate to pool them; therefore, only the
results for the subgroups are given. The pooled relative risk for
death in trauma patients was 0.84 (95% CI 0.69 to 1.04), for
patients with burns 1.49 (95% CI 0.56 to 3.95) and for patients
undergoing surgery 0.51 (95% CI 0.09 to 2.73). Only one trial
gave data on disability (Cooper 2004) and the relative risk for a
poor outcome was 1.00 (95% CI 0.82 to 1.22).
D I S C U S S I O N
This review does not give us enough data to be able to say whether
hypertonic crystalloid is better than isotonic crystalloid for the
resuscitation of patientswith traumaor burns, or those undergoing
surgery. However, the confidence intervals are wide and do not
exclude clinically significant differences between hypertonic and
isotonic crystalloid. A previous review (Perel 2007) found there
was a trend towards a favourable effect on mortality for colloids in
hypertonic crystalloid compared to isotonic crystalloids. However,
those results are compatible with the play of chance.
We chose not to pool the results of the burns, surgery and trauma
patients, as we felt these groups were too clinically heterogeneous.
Bleeding and fluid management in patients undergoing elective
surgery would tend to be more controlled and, therefore, different
to that in trauma patients.
Most of the trials are small and quality was judged to be adequate
in only five of them. There was variation in the type of partici-
pants, and length of follow-up, and little standardisation in terms
of fluid regimes. Also some of the trials were old. Although older
trials will not necessarily be of poorer quality, it may be that treat-
ment protocols have subsequently altered, making these trials less
relevant to current clinical practice. Indeed in the 1970s and 1980s
there were few protocols on fluid resuscitation in the critically ill.
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Since the late 1980s, there have been more clear guidelines and
standardisation of fluid resuscitation regimes, although many ar-
eas of contention still exist.
Mortality was selected as the main outcome measure in this sys-
tematic review for several reasons. In the context of critical illness,
death or survival is a clinically relevant outcome that is of imme-
diate importance to patients, and data on death are reported in
many of the studies. Furthermore, one might expect that mor-
tality data would be less prone to measurement error or biased
reporting than would data on pathophysiological outcomes. The
use of a pathophysiological end-point as a surrogate for an ad-
verse outcome assumes a direct relationship between the two, an
assumption that may sometimes be inappropriate. Finally, when
trials collect data on a number of physiological end-points, there
is the potential for bias, due to the selective publication of end-
points showing striking treatment effects.
Hypertonic solutions have been proposed as the fluid of choice in
patients with head injuries (Walsh 1991), as they may maintain
cerebral perfusion pressure without causing brain swelling with
an increase in intracranial pressure. However, we found only one
small trial (Simma 1998) among people with head injuries.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review does not provide any evidence that hypertonic crys-
talloid is better than isotonic crystalloid, but it does not rule out
clinically important differences.
Implications for research
Further trials are needed comparing hypertonic to isotonic crystal-
loid. These trials should be multi-centre prospective randomised
controlled trials, that are large enough to detect a clinically im-
portant difference. Clinically relevant outcomes such as mortality
should be used and trials should specify the type and amount of
fluid used.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bortolani 1996
Methods Randomised controlled trial. Method of allocation concealment is not described.
No mention of blinding.
Participants 40 patients, with burns over 30% of the body surface area admitted within 4 hours of trauma.
Country: Italy
Interventions 1. Hypertonic lactated saline (n=20)
2. Ringer’s lactated saline (n=20)
Outcomes Haemodynamic variables.
Death.
Complications.
Notes Length of follow-up not clear.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Caldwell 1979
Methods Treatments were alternated.
No mention of blinding.
Participants 20 children with thermal burns covering 30% or more of the body surface area.
Country: USA
Interventions 1. Hypertonic lactated Ringer’s (n=17).
2. Lactated Ringer’s (n=20).
i.v. treatment discontinued after 48 hrs.
Outcomes Death.
Haemodynamic variables.
Notes Length of follow-up not clear.
No loss to follow-up reported.
Risk of bias
Item Authors’ judgement Description
8Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Caldwell 1979 (Continued)
Allocation concealment? No C - Inadequate
Cooper 2004
Methods Double blind randomised controlled trial.
Identical bags of sequentially numbered, computer randomised fluid were packed in groups of 4 in each
ambulance
Participants 229 patients with traumatic brain injury.
Country: Australia.
Interventions 1. 250 ml of Hypertonic saline (7.5%).
2. 250 ml of ringers lactate.
Outcomes Death.
Disability (glasgow outcome scale).
Cognitive score.
Functional independence score.
Notes Follow up 6 months.
One patient in control group declined to participate and two in intervention were lost to follow-up
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Croft 1992
Methods Randomised controlled trial. Patients were divided consecutively, with a random allocation chart.Method
of allocation concealment was not described.
No mention of blinding.
Participants 28 patients undergoing major intra-abdominal surgery. Patients with an abnormality of a cardiac valve,
liver failure, pacemaker, shock, septicemia or presence of myocardial ischemia less than 24 hours before
the study were excluded.
Country: Canada.
Interventions 1. Hypertonic saline (n=13).
2. Isotonic Ringer’s lactate (n=15).
Preoperatively RL or HS were infused at a rate sufficient to maintain a PAWP and a CVP within 3 mm
Hg of the initial value
Outcomes Haemodynamic variables.
Death.
9Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Croft 1992 (Continued)
Notes Follow up 72 hours.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Cross 1989
Methods Randomised double-blind study. Method of allocation concealment not described.
Doctors and nurses directly involved in pt care did not know identity of solutions
Participants 20 post-op coronary artery bypass patients. Patients with history of significant arrhythmias, congestive
heart failure, renal, hepatic, or pulmonary failure were excluded.
Country: USA
Interventions 1. Hypertonic saline (n=11).
2. Normal saline (n=9).
for 24 hr period following arrival at ITU.
Study solutions were initially infused at 100 ml/hr, subsequent rates were adjusted according to the clinical
status and were infused to maintain hemodynamic stability
Outcomes Death.
Hemodynamic variables.
Notes Follow-up 24 hours.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Gunn 1989
Methods Randomised controlled trial. Method of allocation concealment not described
Participants 51 adult patients who sustained at least 20% body surface area burns and who were admitted within 12
hours of injury
Interventions 1. Hypertonic sodium lactate
2. Ringer’s lactate.
Intravenous fluid was administered to maintain the urine output at a target rate of 0.5-1.0 cc/kg/hour,
and maintain a minimal or zero base deficit in serial blood gas analyses
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Gunn 1989 (Continued)
Outcomes Hemodynamic variables.
Enteral intake.
Notes Follow-up was for 72 hours. High drop-out rate due to need for surgery, excision and grafting. These
patients were not followed up after surgery
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Jarvela 2002
Methods Randomised controlled trial. Patients were randomly allocated according to a list of random digits to 2
groups.
Blinding not specified.
Participants 72 patients undergoing elective coronary artery bypass graft surgery. Patients were excluded if they had a
left ventricular ejection fraction less than 0.4, a serum creatinine more than 130 umol/L, hepatic or renal
disease, or continuous medication with diuretics.
Country: Finland.
Interventions 1. Hypertonic saline (7.5%) (n=36).
2. Normal saline (0.9%) (n=36).
Both groups received 4ml/kg during 30 minutes, when volume loading was needed during the postopera-
tive warming period in ICU. The infusion was stopped if systemic arterial pressure exceeded 170 mmHg
Outcomes Hemodynamic variables.
MAP.
Cardiac index.
Notes Follow-up first post-op morning.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Jelenko 1978
Methods Randomised controlled trial, method of allocation concealment not described.
Blinding not mentioned.
No loss to follow up.
Participants 12 patients with burns covering more than 20% of body surface.
Country: USA.
Interventions 1. Hypertonic saline (240MeQ Na+, 120 MeQ Chloride, 120 MeQ lactate) (n=5).
2. Ringer’s lactate (n=7).
Allocated fluid was used, guided by haemodynamic variables, to the end of resuscitation
Outcomes Death.
Hemodynamic variables.
Notes Follow-up to the end of resuscitation.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
McGough 1990
Methods Randomised controlled trial. Method of allocation concealement not described
Participants 50 patients undergoing total hip arthroplasty, hysterectomy, or radical prostatectomy
Interventions 1. Hypertonic saline at 4 ml/kg/hr.
2. Ringers lactate at 8 ml/kg/hr.
Outcomes Complications.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Shackford 1983
Methods Patients were assigned by random number to one of two groups. Allocation was done by list of random
numbers read by someone entering the patient into the trial (open list).
No mention of blinding.
Participants 58 patients undergoing aortic reconstruction.
Country: USA.
Interventions 1. Group one received a hypertonic solution (HSL) (n=30).
2. Group two received ringers lactate (n=28).
Fluidwas given tomaintain the cardiac filling pressure within 3 torr of the preoperative level and the cardiac
output at or above the preoperative level. All pts received 5% dextrose in 0.25N saline as a maintenance
solutuion
Outcomes Hemodynamic variables.
Death.
Notes Follow-up three days.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Shackford 1987
Methods Patients were assigned by random number to one of two groups.
Allocation was done by list of random numbers read by someone entering the patient into the trial (open
list).
No mention of blinding.
Participants 52 patients undergoing aortic reconstruction.
Country: USA
Interventions 1. Hypertonic lactated saline (n=26).
2. Ringer’s lactate (n=26).
During and immediately after the operation fluid was given to maintain the CO equal to preoperative
levels and the cardiac filling pressures within 3 torr of the preoperative value. Post-op all of the patients
received 5% dextrose in normal saline as a maintenance solution, this was continued until the first day
post-op. During this same period, additional fluid (eitherHSL or RL) was given to maintain cardiac filling
pressures and CO at pre-op levels
Outcomes Hemodynamic variables.
Serum compositional changes.
Notes Follow-up three days.
Risk of bias
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Shackford 1987 (Continued)
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Simma 1998
Methods Randomized controlled trial. Randomization was done by an independent investigator. Staff were not
blinded to the type of fluid
Participants 32 head-injured children under the age of 16 with Glasgow coma scores of <8. The patients entered the
study at the time when ICP was first measured.
Country: Switzerland.
Interventions 1. Hypertonic saline (n=15).
2. Ringer’s lactate (n=17).
Over 72 hours.
Outcomes Hemodynamic variables.
Complications.
Length of hospital stay.
Death.
Notes Follow-up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Vassar 1990
Methods Randomised controlled trial, allocation concealment unclear.
Double blind study (solutions prepared in identical containers).
No loss to follow up.
Participants 59 injured patients were entered into the trial. Participants were emergency department admissions with
trauma and a systolic blood pressure below 80mm Hg and were 18 years or older.
Pregnant women and people with preexisting cardiac, hepatic or renal disease were excluded.
Country: USA
Interventions 1. 7.5% saline (n=32).
2. Ringer’s lactate (n=27).
Allocated fluids were given as the initial resuscitation fluid in the emergency department
Outcomes Haemodynamic variables.
Death.
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Vassar 1990 (Continued)
Notes Follow-up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Vassar 1993a
Methods Randomised controlled double blind trial. Allocation concealed by random sequence of identical con-
tainers.
36 people excluded post randomisation as deemed not to have met eligibility criteria.
No loss to follow up.
Participants 169 pre-hosptial trauma patients, who were undergoing ambulance transport to an emergency centre, had
systolic blood pressure 90 mmHg or less, and were 18 years or older.
Exclusions: asystolic, undergoing CPR, lack sinus complex on ECG, more than 2 hours after trauma,
pregnant, preexisting seizures, bleeding disorder, hepatic, cardiac or renal disease.
Country: USA
Interventions 1. 7.5% saline (n=85).
2. 0.9% saline (n=84).
Participants received 250mL of the allocated fluid in the pre-hospital setting. Additional isotonic crystal-
loids were given as needed
Outcomes Deaths reported.
Haemodynamic variables.
Trauma scores and neurological outcome scores.
Notes Follow-up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Vassar 1993b
Methods Randomised controlled trial, allocation concealed by sequential use of coded identical containers. Only
the manufacturer could know the treatment assignment.
Double blind study.
39/233 patients excluded as deemed not to meet eligibility criteria, unclear from which groups
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Vassar 1993b (Continued)
Participants 95 pre-hospital trauma patients undergoing helicoptor transport to an emergency centre, had a systolic
blood pressure of 100mmHg or less and were 18 years or older.
Exclusions: asystolic, undergoing CPR, lack sinus complex on ECG, more than 2 hours after trauma,
pregnant, preexisting seizures, bleeding disorder, hepatic, cardiac or renal disease.
Country: USA
Interventions 1. 7.5% saline. (n=50)
2. Ringer’s lactate. (n=45)
Participants received 250mL of the allocated fluid in the pre-hospital setting. Additional isotonic crystal-
loids were given as needed
Outcomes Deaths reported.
Haemodynamic variables.
Trauma scores and neurological outcome scores.
Notes Follow-up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Younes 1988a
Methods Random assignment. Method of allocation concealment not mentioned
Participants 33 patients admitted to the emergency ward in hypovolemic shock (mean arterial pressure < 60 mmHg)
Interventions 1. Hypertonic 7.5% saline (n=18).
2. Isotonic NaCl (n=15).
Both fluids received at infusion rate of 10ml/minute, over 15 minutes. No other fluid was given after the
infusion unless MAP fell below 80mmHg, until typed-crossmatched blood was available. Patients were
excluded from the study as soon as given fluid or blood
Outcomes MAP
Notes Length of follow-up not recorded.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Younes 1988b
Methods Random assignment. Method of allocation concealment not mentioned
Participants 31 patients admitted for abdominal aorta reconstructive surgery
Interventions 1. Hypertonic 7.5% NaCl, (n=18)
2. Isotonic 0.9% saline (n=13)
Both groups received fluid as the volume of 4ml/kg of body weight, infused during 15 minutes. The
infusion was started 2 minutes before the release of the aortic clamp
Outcomes MAP.
Haemodynamic variables.
Notes Length of follow up not recorded.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Younes 1992
Methods Randomised ’in a double blind fashion’.
Blinding by use of similar bottles.
No loss to follow up.
Participants 70 emergency department admissions, who had a systolic blood pressure of less than 80mm Hg and were
19 years and older.
Exclusions: pregnant, preexisting cardiac or metabolic disease
Interventions 1. 7.5% saline (n=35).
2. 0.9% saline (n=35).
Allocated fluid was for initial bolus of 250mL, followed by isotonic crystalloids as needed
Outcomes Deaths reported.
Fluid balance.
Notes Follow-up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
MAP = mean arterial pressure.
ICU = Intensive care unit.
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PCWP = Pulmonary capillary wedge pressure.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Fisher 1992 Cross-over study.
Holcroft 1987 The study was not randomised. Fluid was administered depending on the attending surgeon
Shackford 1998 Study compared hypertonic fluid versus hypotonic.
Shao 2005 The patients were ’assigned’ and not randomised.
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D A T A A N D A N A L Y S E S
Comparison 1. Hypertonic versus isotonic crystalloid
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 14 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Trauma 6 651 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.69, 1.04]
1.2 Burns 3 89 Risk Ratio (M-H, Fixed, 95% CI) 1.49 [0.56, 3.95]
1.3 Surgery 5 230 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.09, 2.73]
2 Poor outcome (GOS) 1 226 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.82, 1.22]
2.1 Trauma 1 226 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.82, 1.22]
Analysis 1.1. Comparison 1 Hypertonic versus isotonic crystalloid, Outcome 1 Death.
Review: Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients
Comparison: 1 Hypertonic versus isotonic crystalloid
Outcome: 1 Death
Study or subgroup Hypertonic Isotonic Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Trauma
Cooper 2004 51/113 60/113 0.85 [ 0.65, 1.11 ]
Simma 1998 0/17 2/15 0.18 [ 0.01, 3.43 ]
Vassar 1990 11/32 7/27 1.33 [ 0.60, 2.94 ]
Vassar 1993a 11/85 14/84 0.78 [ 0.37, 1.61 ]
Vassar 1993b 20/50 23/45 0.78 [ 0.50, 1.22 ]
Younes 1992 7/35 8/35 0.88 [ 0.36, 2.15 ]
Subtotal (95% CI) 332 319 0.84 [ 0.69, 1.04 ]
Total events: 100 (Hypertonic), 114 (Isotonic)
Heterogeneity: Chi2 = 2.47, df = 5 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.59 (P = 0.11)
2 Burns
Bortolani 1996 5/20 3/20 1.67 [ 0.46, 6.06 ]
Caldwell 1979 2/17 1/20 2.35 [ 0.23, 23.75 ]
Jelenko 1978 1/5 2/7 0.70 [ 0.09, 5.76 ]
0.1 0.2 0.5 1 2 5 10
Hypertonic Isotonic
(Continued . . . )
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(. . . Continued)
Study or subgroup Hypertonic Isotonic Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Subtotal (95% CI) 42 47 1.49 [ 0.56, 3.95 ]
Total events: 8 (Hypertonic), 6 (Isotonic)
Heterogeneity: Chi2 = 0.67, df = 2 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 0.80 (P = 0.42)
3 Surgery
Croft 1992 0/13 1/15 0.38 [ 0.02, 8.62 ]
Cross 1989 0/11 0/9 0.0 [ 0.0, 0.0 ]
Jarvela 2002 0/36 1/36 0.33 [ 0.01, 7.92 ]
Shackford 1983 1/30 1/28 0.93 [ 0.06, 14.22 ]
Shackford 1987 0/26 0/26 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 116 114 0.51 [ 0.09, 2.73 ]
Total events: 1 (Hypertonic), 3 (Isotonic)
Heterogeneity: Chi2 = 0.29, df = 2 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 0.79 (P = 0.43)
0.1 0.2 0.5 1 2 5 10
Hypertonic Isotonic
Analysis 1.2. Comparison 1 Hypertonic versus isotonic crystalloid, Outcome 2 Poor outcome (GOS).
Review: Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients
Comparison: 1 Hypertonic versus isotonic crystalloid
Outcome: 2 Poor outcome (GOS)
Study or subgroup Hypertonic Isotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Trauma
Cooper 2004 71/113 71/113 100.0 % 1.00 [ 0.82, 1.22 ]
Total (95% CI) 113 113 100.0 % 1.00 [ 0.82, 1.22 ]
Total events: 71 (Hypertonic), 71 (Isotonic)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
0.1 0.2 0.5 1 2 5 10
Hypertonic Isotonic
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A P P E N D I C E S
Appendix 1. Search strategy
Injuries Specialised Register; searched 03-10-07
(hypertonic* or isotonic* or hyperosmotic* or hyperoncotic*) or (“hypotensive resuscitation”) or (“Isotonic Solutions”)
CENTRAL up to issue 3, 2007
Searched 02-10-07
#1 exp Saline Solution, Hypertonic/
#2 exp Isotonic Solutions/
#3 hypertonic* or isotonic* or hyperosmotic* or hyperoncotic*
#4 hypotensive next resuscitation
#5 #1 or #2 or #3 or #4
MEDLINE up to Sept, week 3, 2007
Searched 02-10-07
1. exp Saline Solution, Hypertonic/
2. exp Isotonic Solutions/
3. (hypertonic$ or isotonic$ or hyperosmotic$ or hyperoncotic$).ab,ti.
4. hypotensive resuscitation.mp.
5. 1 or 2 or 3 or 4
6. (2004$ or 2005$ or 2006$ or 2007$).em.
7. 5 and 6
8. (randomised or randomized or randomly or random order or random sequence or random allocation or randomly allocated or at
random or controlled clinical trial$).tw,hw.
9. clinical trial.pt.
10. 8 or 9
11. exp models, animal/
12. exp Animals/
13. exp Animal Experimentation/
14. exp Disease Models, Animal/
15. exp Animals, Laboratory/
16. or/11-15
17. Humans/
18. 16 not 17
19. 10 not 18
20. 7 and 19
EMBASE up to Sept (week 39), 2007
Searched 02-10-07
1. exp Hypertonic Solution/
2. exp Isotonic Solution/
3. (hypertonic$ or isotonic$ or hyperosmotic$ or hyperoncotic$).ab,ti.
4. hypotensive resuscitation.mp.
5. or/1-4
6. exp animal model/
7. Animal Experiment/
8. exp ANIMAL/
9. exp Experimental Animal/
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(Continued)
10 .6 or 7 or 8 or 9
11. Human/
12. 10 not 11
13. (randomised or randomized or randomly or random order or random sequence or random allocation or randomly allocated or at
random or controlled clinical trial$).tw,hw.
14. exp clinical trial/
15. 13 or 14
16. 15 not 12
17. 5 and 16
18. (2004$ or 2005$ or 2006$ or 2007$).em.
19. 17 and 18
NRR up to issue 3, 2007
Searched 03-10-07
#1 hypertonic* or isotonic* or hyperosmotic* or hyperoncotic*)
#2 (hypotensive next resuscitation)
#3 (isotonic next solution*)
#4 (hypertonic next solution*)
#5 SALINE SOLUTION HYPERTONIC explode all trees (MeSH)
#6 ISOTONIC SOLUTIONS explode all trees (MeSH)
#7 #1 or #2 or #3 or #4 or #5 or #6
Zetoc (2004-2007)
searched 03-10-07
Hypertonic* random*
Or
Isotonic* random*
Or
Hypotensive resusc* random*
F E E D B A C K
Lactated Ringer’s not isotonic
Summary
Lactated Ringer’s solution is not a truly isotonic fluid. In one report (Tommasino C, Moore S, Todd MM. Crit Care Med 1988;16
p867) the measured osmolality was stated to be approximately 254 mosm/l while the calculated osmolality was 273 mosm/l.
The treatment of traumatized patients will include the infusion of many literes of crystalloids during the first hours. In comparison, the
250 ml of lactated Ringer’s or saline used at intervention in the studies concerned probably does not matter very much. The problem
addressed by the review, rather than one of “isotonic versus hypotonic”, may be more precisely formulated as something like “early
supplementation or not” of hypertonic fluid to the continued use of many liters of a weakly hypotonic fluid.
The hypothesis that 250 ml of hypertonic fluid is beneficial, may easily lead to the idea that many litres of a hypotonic fluid is
detrimental. Or is the hypertonic fluid of benefit only when it is added to adjust for the hypotonic one? Will a test with really isotonic
crystalloid do better than the hypotonic one and show the supplementation with hypertonic fluid not only to be unnecessary, but even
harmful?
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The reports often conceal the true nature of the fluids used behind designations like “conventional isotonic solutions” or “standard of
care”, and the amount of fluid given after arrival in hospital may not be stated.
Implications for research is that studies with the continued use of truly isotonic solutions have to be done to decide whether hypertonic
or weakly hypotonic solutions are beneficial or detrimental. The nature and amount of fluids used in future studies should be clearly
stated.
I certify that I have no affiliations with or involvement in any organisation or entity with a direct financial interest in the subject matter
of my criticisms.
Reply
We agree that lactated Ringer’s is not a truly isotonic fluid and have, therefore, changed the title of the review to reflect this. The title
is now ’Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients’.
We also agree that the nature and amount of fluids used in future studies should be clearly stated, and have included a statement to
this effect in the conclusions.
Contributors
Comment by Per Størset (anesthesiologist), December 2002.
Reply from Frances Bunn, May 2004.
WH A T ’ S N E W
Last assessed as up-to-date: 14 October 2007.
Date Event Description
10 July 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 2, 2000
Review first published: Issue 4, 2000
Date Event Description
20 February 2008 New search has been performed This review was originally published in the Cochrane Library in 2000. It has
subsequently been updated in 2001, 2004, and, most recently, 2008. No new
studies were added in the most recent update
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C O N T R I B U T I O N S O F A U T H O R S
FB screened citations for eligibility, obtained references, contacted authors, extracted data, entered data and wrote up the review. IR
helped to write the review. RT commented on the protocol and review. DT screened citations for eligibility.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• University of Hertfordshire, UK.
External sources
• NHS Research and Development, UK.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Plasma Substitutes; Critical Illness; Hypertonic Solutions [∗therapeutic use]; Hypovolemia [mortality; ∗therapy]; Isotonic Solutions
[∗therapeutic use]; Randomized Controlled Trials as Topic; Rehydration Solutions [∗therapeutic use]
MeSH check words
Humans
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